Xuezhi He

2.6k total citations
30 papers, 1.8k citations indexed

About

Xuezhi He is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Xuezhi He has authored 30 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 27 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Xuezhi He's work include Cancer-related molecular mechanisms research (27 papers), RNA modifications and cancer (26 papers) and RNA Research and Splicing (12 papers). Xuezhi He is often cited by papers focused on Cancer-related molecular mechanisms research (27 papers), RNA modifications and cancer (26 papers) and RNA Research and Splicing (12 papers). Xuezhi He collaborates with scholars based in China, Tunisia and United States. Xuezhi He's co-authors include Erbao Zhang, Wei De, Dandan Yin, Liang Han, Xiyi Lu, Xinxin Si, Jinfei Chen, Jun Su, Min Xie and Tongpeng Xu and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Cancer Research.

In The Last Decade

Xuezhi He

28 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuezhi He China 22 1.6k 1.6k 164 154 107 30 1.8k
Fengqi Nie China 22 1.9k 1.2× 1.9k 1.2× 114 0.7× 153 1.0× 110 1.0× 28 2.2k
Dan Tao China 14 1.4k 0.8× 1.2k 0.7× 77 0.5× 39 0.3× 57 0.5× 16 1.5k
Zhongqiu Lin China 17 780 0.5× 754 0.5× 56 0.3× 114 0.7× 159 1.5× 37 1.1k
Kai Wu China 21 730 0.5× 618 0.4× 98 0.6× 73 0.5× 206 1.9× 42 1.1k
Dakui Luo China 15 479 0.3× 468 0.3× 184 1.1× 69 0.4× 268 2.5× 48 877
Binhui Ren China 17 568 0.4× 394 0.2× 135 0.8× 33 0.2× 151 1.4× 33 848
Daniela Cimino Italy 13 944 0.6× 702 0.4× 38 0.2× 29 0.2× 147 1.4× 16 1.2k

Countries citing papers authored by Xuezhi He

Since Specialization
Citations

This map shows the geographic impact of Xuezhi He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuezhi He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuezhi He more than expected).

Fields of papers citing papers by Xuezhi He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuezhi He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuezhi He. The network helps show where Xuezhi He may publish in the future.

Co-authorship network of co-authors of Xuezhi He

This figure shows the co-authorship network connecting the top 25 collaborators of Xuezhi He. A scholar is included among the top collaborators of Xuezhi He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuezhi He. Xuezhi He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qu, Tianyu, Chang Zhang, Xiyi Lu, et al.. (2025). 8q24 derived ZNF252P promotes tumorigenesis by driving phase separation to activate c-Myc mediated feedback loop. Nature Communications. 16(1). 1986–1986. 4 indexed citations
2.
He, Xuezhi, Jing Wang, Juan Liu, et al.. (2023). DLEU2/EZH2/GFI1 Axis Regulates the Proliferation and Apoptosis of Human Bone Marrow Mesenchymal Stem Cells. Critical Reviews in Eukaryotic Gene Expression. 34(3). 61–71.
3.
Wang, Jing, Xuezhi He, Qing Yao, et al.. (2023). LncRNA PTTG3P promotes tumorigenesis and metastasis of NSCLC by binding with ILF3 to maintain mRNA stability and form a positive feedback loop with E2F1. International Journal of Biological Sciences. 19(13). 4291–4310. 12 indexed citations
4.
Zhu, Qingqing, Chongguo Zhang, Tianyu Qu, et al.. (2022). MNX1-AS1 Promotes Phase Separation of IGF2BP1 to Drive c-Myc–Mediated Cell-Cycle Progression and Proliferation in Lung Cancer. Cancer Research. 82(23). 4340–4358. 65 indexed citations
6.
Chen, Lu, Dawei Rong, Bingqing Hui, et al.. (2021). CircETFA upregulates CCL5 by sponging miR-612 and recruiting EIF4A3 to promote hepatocellular carcinoma. Cell Death Discovery. 7(1). 321–321. 23 indexed citations
7.
He, Xuezhi, Jing Wang, Jin Chen, et al.. (2019). lncRNA UCA1 Predicts a Poor Prognosis and Regulates Cell Proliferation and Migration by Repressing p21 and SPRY1 Expression in GC. Molecular Therapy — Nucleic Acids. 18. 605–616. 33 indexed citations
8.
Yu, Yang, Mingjiong Zhang, Ni Wang, et al.. (2018). Epigenetic silencing of tumor suppressor gene CDKN1A by oncogenic long non-coding RNA SNHG1 in cholangiocarcinoma. Cell Death and Disease. 9(7). 746–746. 44 indexed citations
9.
10.
Yu, Yang, Mingjiong Zhang, Jian Yang, et al.. (2018). Long Non-coding RNA PVT1 Promotes Cell Proliferation and Migration by Silencing ANGPTL4 Expression in Cholangiocarcinoma. Molecular Therapy — Nucleic Acids. 13. 503–513. 62 indexed citations
11.
Ma, Tianshi, Xuezhi He, Jin‐Xing Zhou, et al.. (2018). Long intergenic non-coding RNA 00324 promotes gastric cancer cell proliferation via binding with HuR and stabilizing FAM83B expression. Cell Death and Disease. 9(7). 717–717. 84 indexed citations
12.
Wu, Dan, Yetao Xu, Yanfen Zou, et al.. (2018). Long Noncoding RNA 00473 Is Involved in Preeclampsia by LSD1 Binding-Regulated TFPI2 Transcription in Trophoblast Cells. Molecular Therapy — Nucleic Acids. 12. 381–392. 33 indexed citations
13.
Zhang, Erbao, Xuezhi He, Chongguo Zhang, et al.. (2018). A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1. Genome biology. 19(1). 154–154. 221 indexed citations
14.
Lu, Xiyi, Xuezhi He, Jun Su, et al.. (2018). EZH2-Mediated Epigenetic Suppression of GDF15 Predicts a Poor Prognosis and Regulates Cell Proliferation in Non-Small-Cell Lung Cancer. Molecular Therapy — Nucleic Acids. 12. 309–318. 30 indexed citations
15.
Lu, Xiyi, Chenjun Huang, Xuezhi He, et al.. (2017). A Novel Long Non-Coding RNA, SOX21-AS1, Indicates a Poor Prognosis and Promotes Lung Adenocarcinoma Proliferation. Cellular Physiology and Biochemistry. 42(5). 1857–1869. 48 indexed citations
16.
Su, Jun, Erbao Zhang, Liang Han, et al.. (2017). Long noncoding RNA BLACAT1 indicates a poor prognosis of colorectal cancer and affects cell proliferation by epigenetically silencing of p15. Cell Death and Disease. 8(3). e2665–e2665. 84 indexed citations
17.
Ji, Hao, Juan Li, Haiyan Wang, et al.. (2017). Long noncoding RNA CRNDE promotes colorectal cancer cell proliferation via epigenetically silencing DUSP5/CDKN1A expression. Cell Death and Disease. 8(8). e2997–e2997. 127 indexed citations
18.
Zhang, Erbao, Liang Han, Dandan Yin, et al.. (2016). H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma. Nucleic Acids Research. 45(6). 3086–3101. 268 indexed citations
19.
He, Xuezhi, Zhili Liu, Jinsong Yang, et al.. (2016). Low expression of long noncoding RNA CASC2 indicates a poor prognosis and regulates cell proliferation in non-small cell lung cancer. Tumor Biology. 37(7). 9503–9510. 67 indexed citations
20.
Zhang, Erbao, Xuezhi He, Dandan Yin, et al.. (2016). Increased expression of long noncoding RNA TUG1 predicts a poor prognosis of gastric cancer and regulates cell proliferation by epigenetically silencing of p57. Cell Death and Disease. 7(2). e2109–e2109. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026